The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Oral Lichen Planus Advanced Treatment

Chronic mucocutaneous inflammatory disease of the oral cavity

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Ağız ve Diş Sağlığı department. Book Appointment →

What is Oral Lichen Planus Advanced Treatment?

Oral lichen planus (OLP) is a chronic inflammatory disorder mediated by activated T lymphocytes targeting basal keratinocytes through cell-mediated cytotoxicity and apoptosis. Six clinical subtypes are recognized: reticular (most common, asymptomatic, Wickham striae), papular, plaque-like, erythematous (atrophic), erosive (ulcerative, painful), and bullous (rare). The disease typically affects women aged 30-60 years with bilateral involvement of buccal mucosa, tongue, and gingiva.

Etiology is multifactorial including autoimmune mechanisms, hepatitis C virus association (especially in Mediterranean populations), drug-induced lichenoid reactions (NSAIDs, beta-blockers, ACE inhibitors, antimalarials), dental restoration materials (amalgam, gold), and graft-versus-host disease following stem cell transplantation. OLP is recognized as a potentially malignant disorder with squamous cell carcinoma transformation rate of 0.4-5% over decades.

Diagnosis is clinical with confirmation by biopsy showing characteristic histopathology (basal cell liquefactive degeneration, hyperkeratosis, band-like lymphocytic infiltrate at lamina propria-epithelium junction). Direct immunofluorescence helps distinguish OLP from autoimmune blistering diseases. Treatment is symptomatic and disease-modifying with topical corticosteroids first-line (clobetasol, fluocinonide), topical calcineurin inhibitors (tacrolimus, pimecrolimus), systemic corticosteroids and immunosuppressants for severe disease, and lifelong oral cancer surveillance with biannual examinations and biopsy of suspicious lesions.

Symptoms

Reticular: white lacy patterns (Wickham striae) on buccal mucosa, tongue, gingiva
Papular: small white papules
Plaque-like: white plaques resembling leukoplakia
Erythematous (atrophic): red, thinned, sensitive areas
Erosive (ulcerative): painful ulcers and erosions
Bullous: blisters and bullae (rare)
Bilateral and often symmetric distribution
Buccal mucosa most commonly affected
Tongue, gingiva, lip involvement
Burning sensation
Pain, especially with spicy or acidic foods
Difficulty eating, drinking, brushing
Taste alteration
Sensitivity to hot, cold, spicy, acidic foods
Concurrent skin lichen planus (15%) — purplish polygonal papules
Genital, scalp, nail involvement
Esophageal involvement (rare)
Gingival involvement (desquamative gingivitis)
Recurrent episodes with periods of remission
Quality-of-life impairment in erosive form

Risk Factors

Female sex (3:1)
Age 30-60 years
Hepatitis C virus infection (Mediterranean, Asian populations)
Liver disease
Dental restoration materials (amalgam, gold, nickel)
Drug exposure (NSAIDs, beta-blockers, ACE inhibitors, hydroxychloroquine, gold, sulfonylureas, allopurinol)
Stress, anxiety
Family history (genetic predisposition)
Bone marrow or stem cell transplantation (chronic GVHD)
Autoimmune disorders (especially with concurrent oral lichen planus)
Vitiligo, alopecia areata
Ulcerative colitis, Crohn disease
Hashimoto thyroiditis
Diabetes mellitus type 2
Hypertension
Chronic hepatitis B (less common)
Smoking (controversial)
Spicy or acidic foods (trigger symptoms but not cause)
Hormonal changes
Dental trauma

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Persistent white lacy patterns in oral cavity
  • Painful red areas or ulcers in mouth
  • Bilateral oral lesions
  • Bleeding gums with red and white patches
  • Pain with eating, especially spicy or acidic foods
  • Burning sensation in mouth
  • Recurrent oral lesions
  • Genital, skin, scalp, nail lesions with oral involvement
  • Hepatitis C diagnosis with oral lesions
  • Suspicious lesion (especially red, ulcerated, asymmetric, or new)
  • Routine surveillance for known OLP
  • Following dental procedure with new lesion
  • Drug initiation followed by oral lesions
  • Considering biopsy for diagnosis
  • Quality-of-life impairment from oral symptoms

Treatment Methods

01
Comprehensive evaluation by oral medicine specialist or dermatologist
02
Detailed history including symptoms, duration, distribution, drugs, dental restorations, comorbidities
03
Clinical examination with bilateral and symmetric oral lesion documentation
04
Photographic documentation
05
Hepatitis C testing (especially in Mediterranean and Asian populations)
06
Patch testing for dental material allergy if suspected
07
Drug history review for lichenoid reactions
08
Biopsy for diagnostic confirmation (essential for atypical or suspicious lesions)
09
Histopathology showing basal cell liquefactive degeneration, hyperkeratosis, band-like lymphocytic infiltrate
10
Direct immunofluorescence to exclude autoimmune blistering diseases
11
Topical corticosteroids first-line: clobetasol propionate 0.05%, fluocinonide 0.05%, betamethasone 0.05% in adhesive paste or rinses
12
Topical calcineurin inhibitors: tacrolimus 0.1% ointment, pimecrolimus 1% cream
13
Topical retinoids for hyperkeratotic lesions
14
Topical antifungals if Candida superinfection
15
Topical hyaluronic acid
16
Mouth rinses with antiseptics, lidocaine for pain
17
Systemic corticosteroids for severe erosive disease (prednisone 0.5-1 mg/kg/day, taper over weeks)
18
Hydroxychloroquine 200 mg twice daily
19
Methotrexate, azathioprine, mycophenolate for refractory disease
20
Cyclosporine systemic or topical (rare)
21
Biologics (TNF inhibitors, low-dose IL-17 inhibitors) for refractory cases — limited evidence
22
Treat underlying hepatitis C with antivirals
23
Replace dental restorations if positive patch test or temporal correlation
24
Discontinue lichenoid drugs when possible
25
Remove triggers: smoking, alcohol, spicy/acidic foods (acute exacerbation)
26
Stress management
27
Oral hygiene optimization
28
Lifelong surveillance for malignant transformation: biannual examinations with biopsy of suspicious lesions
29
Periodic photographic monitoring
30
Education on warning signs (new induration, ulceration not healing, asymmetric growth)
31
Multidisciplinary care: oral medicine, dermatology, hepatology, gastroenterology

Which Department to Visit?

You can visit our Ağız ve Diş Sağlığı department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Ağız ve Diş Sağlığı Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.